Parnax Lab

Parnax Lab P/B

The P/B (Price-to-Book Ratio) of Parnax Lab (506128.BO) as of Nov 18, 2026 is 1.72. In the previous year, P/B (Price-to-Book Ratio) was 1.99 — a change of -13.87% (lower).

P/B

1.72

YoY

-13.87%

Last updated:

P/B (Price-to-Book Ratio) of Parnax Lab is 2025 1.72 . P/B (Price-to-Book Ratio) of Parnax Lab was 2024 1.99 . It decreases by -13.87% lower compared to the previous year.

The Parnax Lab P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
4.39 INR
Jan 1, 2019
4.00 INR
Jan 1, 2020
4.35 INR
Jan 1, 2021
4.39 INR
Jan 1, 2022
2.96 INR
Jan 1, 2023
2.30 INR
Jan 1, 2024
1.99 INR
Jan 1, 2025
1.72 INR
The Parnax Lab P/B history
YEARP/BYoY
1.72-13.87%
1.99-13.16%
2.30-22.47%
2.96-32.46%
4.39+0.77%
4.35+8.95%
4.00-9.01%
4.39-3.97%
4.57-11.47%
5.16-9.05%
5.68-16.89%
6.83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

P/B (Price-to-Book Ratio) of Parnax Lab is 1.72 in 2025.

P/B (Price-to-Book Ratio) of Parnax Lab changed from 1.99 to 1.72, representing a -13.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Parnax Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Parnax Lab

All Key Metrics — Parnax Lab